Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CCME GlobalBOM:514336 -4.97%26 Buyback Yield % is -6.05 as of Aug. 08, 2026. GuruFocus rates BOM:514336 with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 733 Biotechnology companies, CCME Global ranks better than 57.44% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for CCME Global's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:514336 vs VRTX, REGN, RVMD: Buyback Yield % Comparison
For the Biotechnology subindustry, CCME Global's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CCME Global Buyback Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CCME Global's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where CCME Global's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CCME Global (BOM:514336) has a Buyback Yield % of -6.05 as of Aug. 08, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on CCME Global and its competitors. According to the industry distribution chart, CCME Global ranks #312 out of 733 companies in the Biotechnology industry, placing it in the top 42.6%.
Is CCME Global's Buyback Yield % too high?
CCME Global's current Buyback Yield % is -6.05. Based on the distribution chart, CCME Global ranks #312 out of 733 companies in the Biotechnology industry, which is above the industry midpoint. Overall, CCME Global has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does CCME Global's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CCME Global ranks #312 out of 733 companies for Buyback Yield %. This puts CCME Global in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on CCME Global and its competitors. CCME Global's current Buyback Yield % is -6.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CCME Global stock overvalued right now?
CCME Global (BOM:514336) has a current Buyback Yield % of -6.05. The current Buyback Yield % is -6.05. CCME Global's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For CCME Global (BOM:514336), the current Buyback Yield % is -6.05 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CCME Global Ltd, formerly known as Genesis IBRC India Ltd, is a manufacturer and supplier of Aqua, poultry, veterinary and agriculture products. The product profile promotes health and illness prevention in Aquaculture, poultry and veterinary.
26GF Score
Get the complete analysis for BOM:514336
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:514336 has been successfully added to your 
